Apple and OpenEvidence Launch Large-Scale Study on AI Health Chatbots

2 min read
Source: STAT
Apple and OpenEvidence Launch Large-Scale Study on AI Health Chatbots
Photo: STAT
TL;DR

Apple and OpenEvidence have launched a major research study involving up to 200,000 U.S. participants to evaluate the efficacy and trustworthiness of AI-powered health chatbots. The initiative uses a new iOS app that integrates OpenEvidence’s clinical AI platform with Apple HealthKit data, aiming to assess how conversational AI can help consumers understand medical information and prepare for doctor visits without replacing professional care.

Key points

  • Apple and OpenEvidence announced a collaborative study at the HLTH conference in Las Vegas on November 15, 2026, focusing on the interaction between consumers and conversational health AI.
  • The study, titled the Apple Health AI Usage Study, aims to enroll up to 200,000 participants in the United States to measure user trust, comprehension, and response quality.
  • The experimental app allows users to optionally connect personal health data from Apple HealthKit to receive personalized answers grounded in peer-reviewed medical journals via OpenEvidence.
  • Apple’s VP of Health and Fitness, Sumbul Desai, emphasized the company’s commitment to scientific rigor, while OpenEvidence CEO Daniel Nadler highlighted the complementary trust levels of both brands among consumers and doctors, respectively.
  • The initiative seeks to determine if AI tools can bridge the gap between complex medical information and patient understanding, potentially improving preparation for medical appointments.

Background

This launch follows recent delays in Apple’s broader Health app redesign, which was pulled from the iOS 27.2 beta in October 2026 and pushed to a later release. The new study represents a distinct, experimental approach to integrating AI into consumer health interfaces, separate from the delayed native app updates.

Why it matters

This partnership signals a significant shift in how major tech and medical AI companies approach consumer health interfaces, prioritizing rigorous clinical validation over rapid feature deployment. By combining Apple’s consumer trust with OpenEvidence’s clinical credibility, the study could set new standards for how AI chatbots are evaluated and trusted in healthcare settings, potentially influencing future regulatory and design guidelines for health tech.

What to watch

The study will proceed with data collection from up to 200,000 participants to analyze metrics such as user trust and response comprehension. Results may inform future iterations of Apple’s health ecosystem and OpenEvidence’s consumer-facing tools, potentially leading to new benchmarks for AI integration in personal health management.

Share this article

Want the full story? Read the original reporting

Read on STAT